Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy(PLoS ONE (2015) 10:3 (e0121207) 10.1371/journal.pone.0121207)

Young Ho Lee, Xiyong Liu, Fuming Qiu, Timothy R. O'Connor, Yun Yen, David K. Ann

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)

指紋

深入研究「Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy(PLoS ONE (2015) 10:3 (e0121207) 10.1371/journal.pone.0121207)」主題。共同形成了獨特的指紋。